https://www.selleckchem.com/pr....oducts/pkm2-inhibito
gram are needed to better delineate the role of specific interventions in the complex setting of obesity. Obesity remains a challenging and often refractory clinical scenario with emerging evidence indicating the potential role of systemic inflammation, toxin load and endotoxemia. A group therapeutic lifestyle change program enhanced with a detoxification component is feasible and may provide a promising intervention for achieving weight loss while also addressing functional and pain related co-morbidities. Future ran
Aimer
Commentaire
Partagez
